糖吉医疗负债率超136%冲刺港股，1419例手术如何撑起一个IPO？

Core Viewpoint - Tangji Medical is seeking to go public on the Hong Kong Stock Exchange through a special biotech channel, despite facing significant financial losses and operational challenges [1][8]. Financial Performance - The company reported a net loss of 65.957 million RMB for 2024, with a further loss of 54.942 million RMB in the first nine months of 2025, marking an 18.45% year-on-year increase in losses [3][4]. - Revenue for 2024 was only 12.709 million RMB, while total expenses for sales, marketing, administration, and R&D reached over 75 million RMB, indicating a severe imbalance between revenue and costs [3][4]. - Cash outflows from operating activities were 43.568 million RMB in 2024 and 49.043 million RMB in the first nine months of 2025, with total assets of 77.751 million RMB against total liabilities of 106 million RMB, resulting in a debt ratio exceeding 136% [4]. Business Model and Product - The core product, the Gastric Bypass Stent (GBS), is the first approved device in China for endoscopic treatment of obesity, viewed as a key growth driver, but its commercial prospects are uncertain [5][6]. - GBS faces competition from GLP-1 receptor agonist weight loss drugs and traditional weight loss surgeries, which are becoming mainstream due to their convenience and effectiveness [6]. - The company heavily relies on distribution channels, with 99.1% and 99.6% of revenue coming from distributors in 2024 and the first nine months of 2025, respectively [6]. Governance and Control - The founder, Zuo Yuxing, controls 35.94% of the company shares directly and through an employee stock ownership platform, maintaining a controlling stake post-IPO [11]. - The company aims to leverage the rapid growth in the metabolic disease medical device market through IPO financing, but faces challenges due to ongoing losses, weak cash flow, and a narrow business structure [11]. Future Outlook - The ability of Tangji Medical to reverse its financial difficulties through the IPO remains uncertain and will require time to assess [12].